Daily dose of aspirin may work against colon cancer and gastrointestinal tumors, according to a new study. With regular dose of Aspirin, the research team noticed a considerable reduction in certain cancers. However, the study team recommends that the dose should be taken daily for the result.

The research report has been published online on March 3 in the journal JAMA Oncology. According to the research, there is need of only low dose consumption of medicine everyday to get expected results. Daily consumption for almost six years could finally make the drug work against cancer illness. Aspirin is generally prescribed to treat mild to moderate pain and to reduce fever or inflammation.

Aspirin reduces inflammation and amount of some cancer-causing proteins in the body. However, the researchers haven’t reached at a level where they can suggest use of aspirin to general population to prevent cancer. Additional research would be required to check impact of aspirin and recommend it on daily basis.

"There is scientific evidence that aspirin has an effect on certain biological pathways that can result in cancer. The evidence has reached the point that it may be useful to consider using aspirin to prevent colon cancer,” said senior researcher Dr. Andrew Chan, from Massachusetts General Hospital in Boston.

To conduct research, Dr. Chan and colleagues studied a link between aspirin and cancer patients. More than 130,000 people took part in the study. They had taken part in the long-term Nurses' Health Study and the Health Professionals Follow-up Study.

The study found that in 30 years of follow-up, there were more than 20,000 cancers among more than 88,000 women, and more than 7,500 cancers among nearly 48,000 men. The team noticed 15% lower risk of gastrointestinal cancers and a 19% lower risk for cancers of the colon and rectum.